- Pfc. Bradley Manning is now Pfc. Chelsea Manning: Court says so
- Secret base U.S. special forces used to train Libyans now under terrorist control: report
- 9th suspect in N.C. kidnapping turns self in to FBI
- L.A. sheriff admits to testing flyover spy program without notifying residents
- Foreign minister vows response if Russians are attacked in Ukraine
- Robert Griffin III to drive pace car before Richmond NASCAR race
- Material on Australian shore examined in jet hunt
- Bomb, shooting in Egypt kills 2 police officers
- Tenn. woman receives two-year sentence for stealing $364K meant for homeless veterans
- School bus driver gets probation after kicking autistic girl, 8
Germany orders recall of some Novartis flu shots
BERLIN (AP) - German authorities ordered a recall Thursday of some batches of Novartis flu vaccine as a precautionary measure after the company reported the appearance of small particles in the manufacturing process.
The Paul Ehrlich Institute, which is part of the country’s Ministry of Health, said there had been no reports of particle formation in Germany or of any serious side effects during the current flu season.
“However, in the interest of risk prevention and consumer safety it is necessary to cancel the approval for certain vaccines, since the formation of particles in the vaccine and therefore the risk of serious side effects cannot be ruled out,” Institute President Prof. Klaus Cichutek said in a statement.
The decision affects four batches of the influenza vaccine Begripal and one batch of Fluad. It does not affect the seasonal vaccine Optaflu.
Italy’s health ministry banned the sale of four Novartis flu drugs on Wednesday. These included Fluad and Begripal _ sold as Aggripal in Italy _ as well as two others: Influpozzi Adiuvato and Influpozzi Subunita.
Switzerland’s regulator Swissmedic also suspended deliveries of flu vaccines from Novartis as a preventive measure.
Britain’s Medicines and Healthcare products Regulatory Agency said there was no evidence yet to pull the vaccines off the market but added it was gathering further information on the Novartis vaccines.
The Swiss pharmaceutical company said Thursday it was cooperating with the Ministry of Health in Italy, where the vaccines are produced, and was committed to providing vaccines to patients for the current flu season. There had been no adverse effects reported so far from more than 1 million doses of Agrippal/Begripal and Fluad administered, the Basel-based company said.
“Novartis confirms that these particles can occur in the vaccine manufacturing process and is confident that there is no impact on the safety or efficacy of the vaccine,” it said in a statement.
TWT Video Picks
Feds who send arms against ranch families betray American values
- Nevada rancher Cliven Bundy hailed as patriot, ripped as lawless deadbeat
- CARSON: When government looks more like foe than friend
- Pentagon plans to replace flight crews with 'full-time' robots
- America is an oligarchy, not a democracy or republic, university study finds
- Texas is next! AG warns BLM wants 90,000 acres after Bundy ranch standoff
- IRS revokes conservative group's tax-exempt status over anti-Clinton statements: report
- Tactical advantage: Russian military shows off impressive new gear
- Justice Dept.'s new clemency guidelines: Crack offenders most obvious candidates
- Ukraine claims torture by pro-Russian forces on the heels of Biden's stern warning to Moscow
- EDITORIAL: Voting with one's feet shows folly of liberal economic policies
Top 10 handguns in the U.S.
Celebrity deaths in 2014